November 1, 2013

Mylan expects to be the first to market with a generic version of a drug for treating patients with gout, the company said Friday, though its filing has triggered a lawsuit from the makers of the branded version.

October 31, 2013

Impax Labs and Tolmar announced that the Food and Drug Administration has given final approval to Tolmar's generic version of Solaraze gel.

October 30, 2013

A division of Kroger Co. has placed an initial order for Alkaline88, a bottled water brand produced using a proprietary electrolysis beverage process.

October 30, 2013

A trade group for supplement makers is suggesting that people with diabetes talk to their physicians about chromium picolinate supplementation, based on a recent study.

October 30, 2013

STUF Men’s Defense, a skin care line just for guys, has announced that it is now being sold on Amazon.com.

October 29, 2013

Actavis had sales of $2.01 billion in third quarter 2013, a 57% increase over the same period last year, the drug maker said Tuesday.

October 29, 2013

Generic drug maker Amneal Pharmaceuticals is seeking Food and Drug Administration approval for a gout drug, prompting a lawsuit from the maker of the branded version, according to published reports.

October 25, 2013

The Food and Drug Administration has approved a new opioid painkiller made by Zogenix, the agency said Friday.

October 25, 2013

The Food and Drug Administration plans to recommend stronger regulations for a commonly used opioid painkiller.

October 25, 2013

The Food and Drug Administration plans to officially recommend that products containing 15 mg or less of the opioid painkiller hydrocodone be rescheduled as Schedule II controlled substances, from the current Schedule III classification. While the idea is to combat abuse and misuse of the drugs, pharmacy groups say the rescheduling would make them harder to obtain for patients who legitimately need them.

The desire to combat abuse and misuse of prescription drugs — now a worse problem in the United States than cocaine or heroin — is laudable, but unlike those two drugs, hydrocodone has a legitimate use as a painkiller, and it's the people who are using it properly and legally who will end up losing.

October 23, 2013

The Food and Drug Administration plans to complete its phase out of inhalers that contain ozone-depleting chlorofluorocarbons by the end of the year, the agency said Wednesday.

October 23, 2013

Drug maker Depomed has sold its interests in royalty and milestone payments for several Type 2 diabetes drugs to PDL BioPharma, Depomed said.

October 23, 2013

Drug maker Hospira is investing more than $200,000 at a plant in Rocky Mount, N.C., that will evaluate and test more than 450 products, the company said Wednesday.

October 23, 2013

Out of Africa, which is a line of natural and vegan skin care products using 100% pure, unrefined shea butter, is sponsoring in November the Shine On Sierra Leone’s Cash & Rocket VolunTourism Trip Sierra Leone, which will launch the building of the first and only secondary school in the Bongema Village.

October 22, 2013

The Food and Drug Administration has approved drugs for depression and smoking cessation made by Jubilant Life Sciences, the company said.

October 21, 2013

The Food and Drug Administration has approved a pain drug made by Iroko Pharmaceuticals, Iroko said.

October 21, 2013

The Food and Drug Administration has approved a new drug made by Actelion Pharmaceuticals for treating pulmonary arterial hypertension.

October 17, 2013

UrgentRx — developer of fast-acting, over-the-counter, flavored powder medications — on Thursday announced the addition of CVS, OfficeMax and Paradies Stores to the company's list of retail partners.

October 16, 2013

The Vitamin Shoppe on Wednesday announced the grand opening of its new distribution center in Ashland, Va.

October 15, 2013

Actavis is hoping to become the first to market a generic version of a drug used to treat patients who have become dependent on opioid drugs, triggering a lawsuit from the branded drug's manufacturer.

October 14, 2013

Allergy sufferers will have a new treatment option available to them by the spring allergy season. Sanofi on Friday announced that the Food and Drug Administration approved Nasacort Allergy 24HR nasal spray (triamcinolone intranasal) as an over-the-counter treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older.

October 11, 2013

The global market for drugs to treat constipation resulting from use of opioid painkillers will increase more than tenfold by 2017, according to new research.

October 10, 2013

A subsidiary of Johnson & Johnson has acquired rights to an experimental drug for hepatitis C from GlaxoSmithKline.

October 10, 2013

Over the past century, women have come to recognize the famous Nivea crème tin. Now, the iconic tin has taken on a new form and served as the inspiration for the redesigned packaging across all of theNivea products.